This contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of DUPIXENT 300 MG/2 ML PEN 2ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $6,194.75 and runs from July 2024 through July 2024.
Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, valued up to $999,999,999.00 through December 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.
This contract award does not have a set-aside designation, indicating it was competed on a full and open basis. As a major supplier of pharmaceutical products and medical supplies to the federal government, Amerisourcebergen leverages its extensive supply chain network to fulfill these types of government contracts efficiently.
Generated 9/30/24, 3:44 PM